Skip to main content
Dekker Deacon
( out of 137 reviews )

Dekker Deacon, MD, PhD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Clinic 2C, Dermatology/Melanoma
Salt Lake City
801-587-7000

University of Utah Hospital

Salt Lake City
801-581-2121
  • Dekker C. Deacon, MD, PhD completed his residency in dermatology at the University of Utah and has a special interest in the genetics of skin cancer and skin cancer treatment, including Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma and others. He is a member of the Melanoma Disease Center, and regularly participates in a weekly melanoma multidisciplinary treatment planning conference. In addition to skin cancer, which he treats at both The Huntsman Cancer Institute and the University of Utah Hospital clinics, Dr. Deacon sees general dermatology patients for a wide range of conditions including Actinic Keratoses, Acne, Warts, Psoriasis, Dermatitis, Rosacea, Hives, Rashes, Skin Lesions, Cysts, Skin Infections, Excessive Sweating, Hair and Nail Disease, and Drug Reactions. In his free time, he enjoys spending time hiking, biking, and skiing with his wife.

    Patient Rating

    4.9 /5
    ( out of 137 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    February 22, 2024
    UH HOSPITALS AND CLINICS

    I've seen Dr. Deacon twice and both were great experiences. He helped solve an issue with a scar and treatment for pre-cancerous skin cells on my face. Both resolved within a couple months.

    February 05, 2024
    HUNTSMAN CANCER CENTER

    I am an MD. Dr Deacon is one of the best physicians I have encountered. He is an excellent listener and he asked good questions to clarify about things I had not considered. He did a thorough exam (something many physicians these days have forgotten how to do). He explained his thought process in detail in a way I could understand and he was patient with my questions. And most impressively he 1. checked my insurance formulary to guide his prescription choice (first physician I have seen do that) and recommended good rx for meds he could not find an equivalent on the formulary and 2. he closely tracked my prior use of biologic medications for psoriatic arthritis that had not been effective to recommend a possible more effective treatment plan and reached out to my rheumatologist to coordinate care plans for the future. Amazingly comprehensive all on my first visit. 10++++

    February 05, 2024
    HUNTSMAN CANCER CENTER

    Dr Deacon did a good job of teaching while still addressing my concerns and taking care of me as a patient.

    February 04, 2024
    HUNTSMAN CANCER CENTER

    Dr. Deacon, was Careing for me with his Diagnose and treatment for my medial condition today, gave me vary good details in written instruction on what and how I should care for my self at home until my next appointment. I really appreciate how good he Was with me.

    February 04, 2024
    UH HOSPITALS AND CLINICS

    Informative, concerned , answered all my questions

    January 27, 2024
    UH HOSPITALS AND CLINICS

    Very attentive and knowledgeable. I don't know if we have the total diagnosis yet, but I trust that he will see me through

    January 26, 2024
    UH HOSPITALS AND CLINICS

    Very good listener. Respects patient and patient insights/concerns. Friendly demeanor.

    January 15, 2024
    HUNTSMAN CANCER CENTER

    Dr. Deacon was able to quickly schedule me for a basil cell scrape. Really excellent care.

    January 09, 2024
    HUNTSMAN CANCER CENTER

    I¿m very fortunate to have Dr. Deacon carrying for me. He is truly exceptional.

  • Dekker C. Deacon, MD, PhD completed his residency in dermatology at the University of Utah and has a special interest in the genetics of skin cancer and skin cancer treatment, including Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma and others. He is a member of the Melanoma Disease Center, and regularly participates in a weekly melanoma multidisciplinary treatment planning conference. In addition to skin cancer, which he treats at both The Huntsman Cancer Institute and the University of Utah Hospital clinics, Dr. Deacon sees general dermatology patients for a wide range of conditions including Actinic Keratoses, Acne, Warts, Psoriasis, Dermatitis, Rosacea, Hives, Rashes, Skin Lesions, Cysts, Skin Infections, Excessive Sweating, Hair and Nail Disease, and Drug Reactions. In his free time, he enjoys spending time hiking, biking, and skiing with his wife.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary

    Education history

    Chief Resident Dermatology - University of Utah School of Medicine Chief Resident
    Dermatology - University of Utah School of Medicine Resident
    Internship Internal Medicine Preliminary Year - University of Utah School of Medicine Intern
    Biomedical Sciences - University of California, San Diego Ph.D.
    Professional Medical Medical Scientist Training Program - University of California, San Diego School of Medicine M.D.
    Molecular Biology and Biochemistry - Middlebury College B.A.

    Selected Publications

    Journal Article

    1. Scherzer MT, Deacon DC, Judson-Torres RL (2023). Perilesional Epigenomes Distinguish Melanocytic Nevus Subtypes. J Invest Dermatol, 143(9), 1631-1633. (Read full article)
    2. Kelly BG, Liu T, Deacon DC (2023). Persistent Green-Blue Plaque in a Healthy Woman. JAMA Dermatol, 159(3), 335-336. (Read full article)
    3. Kuceki G, Deacon DC, Secrest AM (2022). Amelanotic Melanoma Treated as Fungal Infection for Years. Case Reports in Dermatological Medicine, 2022(Article ID 2598965), 1-3.
    4. Sahni DR, Deacon DC, Madigan LM (2022). The impact of seasonal temperature variation on the incidence of pernio during the COVID19 pandemic. JAAD Int, 10, 3-5. (Read full article)
    5. Deacon DC, Smith EA, Judson-Torres RL (2021). Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects. Front Med (Lausanne), 8, 642380. (Read full article)
    6. Deacon DC, Madigan LM (2020). Inpatient teledermatology in the era of COVID-19 and the importance of the complete skin examination. JAAD Case Rep, 6(10), 977-978. (Read full article)
    7. Grossman D, Okwundu N, Bartlett EK, Marchetti MA, Othus M, Coit DG, Hartman RI, Leachman SA, Berry EG, Korde L, Lee SJ, Bar-Eli M, Berwick M, Bowles T, Buchbinder EI, Burton EM, Chu EY, Curiel-Lewandrowski C, Curtis JA, Daud A, Deacon DC, Ferris LK, Gershenwald JE, Grossmann KF, Hu-Lieskovan S, Hyngstrom J, Jeter JM, Judson-Torres RL, Kendra KL, Kim CC, Kirkwood JM, Lawson DH, Leming PD, Long GV, Marghoob AA, Mehnert JM, Ming ME, Nelson KC, Polsky D, Scolyer RA, Smith EA, Sondak VK, Stark MS, Stein JA, Thompson JA, Thompson JF, Venna SS, Wei ML, Swetter SM (2021). Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. JAMA Dermatol, 156(9), 1004-1011. (Read full article)
    8. Topham C, Deacon DC, Bowen A, Cipriano SD (2019). More than goosebumps: A case of marked skin dimpling in an infant. Pediatr Dermatol, 36(3), e71-e72. (Read full article)
    9. Deacon DC, Happe CL, Chen C, Tedeschi N, Manso AM, Li T, Dalton ND, Peng Q, Farah EN, Gu Y, Tenerelli KP, Tran VD, Chen J, Peterson KL, Schork NJ, Adler ED, Engler AJ, Ross RS, Chi NC (2019). Combinatorial interactions of genetic variants in human cardiomyopathy. Nat Biomed Eng, 3(2), 147-157. (Read full article)
    10. Veevers J, Farah EN, Corselli M, Witty AD, Palomares K, Vidal JG, Emre N, Carson CT, Ouyang K, Liu C, van Vliet P, Zhu M, Hegarty JM, Deacon DC, Grinstein JD, Dirschinger RJ, Frazer KA, Adler ED, Knowlton KU, Chi NC, Martin JC, Chen J, Evans SM (2018). Cell-Surface Marker Signature for Enrichment of Ventricular Cardiomyocytes Derived from Human Embryonic Stem Cells. Stem Cell Reports, 11(3), 828-841. (Read full article)
    11. Hashem SI, Perry CN, Bauer M, Han S, Clegg SD, Ouyang K, Deacon DC, Spinharney M, Panopoulos AD, Izpisua Belmonte JC, Frazer KA, Chen J, Gong Q, Zhou Z, Chi NC, Adler ED (2015). Brief Report: Oxidative Stress Mediates Cardiomyocyte Apoptosis in a Human Model of Danon Disease and Heart Failure. Stem Cells, 33(7), 2343-50. (Read full article)
    12. Zhang K, Deacon DC, Rao F, Schork AJ, Fung MM, Waalen J, Schork NJ, Nievergelt CM, Chi NC, OConnor DT (2013). Human heart rate: heritability of resting and stress values in twin pairs, and influence of genetic variation in the adrenergic pathway at a microribonucleic acid (microrna) motif in the 3'-UTR of cytochrome b561 [corrected]. J Am Coll Cardiol, 63(4), 358-68. (Read full article)
    13. Qiao H, Prasada Rao HB, Yang Y, Fong JH, Cloutier JM, Deacon DC, Nagel KE, Swartz RK, Strong E, Holloway JK, Cohen PE, Schimenti J, Ward J, Hunter N (2014). Antagonistic roles of ubiquitin ligase HEI10 and SUMO ligase RNF212 regulate meiotic recombination. Nat Genet, 46(2), 194-9. (Read full article)
    14. Yoshioka N, Gros E, Li HR, Kumar S, Deacon DC, Maron C, Muotri AR, Chi NC, Fu XD, Yu BD, Dowdy SF (2012). Efficient generation of human iPSCs by a synthetic self-replicative RNA. Cell Stem Cell, 13(2), 246-54. (Read full article)
    15. Deacon DC, Nevis KR, Cashman TJ, Zhou Y, Zhao L, Washko D, Guner-Ataman B, Burns CG, Burns CE (2010). The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis. Development, 137(11), 1887-96. (Read full article)
    16. Ward JO, Reinholdt LG, Motley WW, Niswander LM, Deacon DC, Griffin LB, Langlais KK, Backus VL, Schimenti KJ, OBrien MJ, Eppig JJ, Schimenti JC (2007). Mutation in mouse hei10, an e3 ubiquitin ligase, disrupts meiotic crossing over. PLoS Genet, 3(8), e139. (Read full article)
  • News & Podcasts